May 11, 2026 · Form 4 insider transaction
Goeltz II Robert C. sold 7,763 shares of Arcus Biosciences, Inc. at $25.63 per share, a transaction worth $199.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.; Includes the unvested portion of the reporting person's RSU grants.